Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 8, 2013Blood

JAK of all trades: JAK2-STAT5 as novel therapeutic targets in BCR-ABL1+ chronic myeloid leukemia

View Full Paper
Ask AI
Bookmark
Share

Authors

WWWolfgang WarschUniversity of ViennaCWChristoph WalzLMU KlinikumVSVeronika SexlUniversity of Veterinary Medicine Vienna

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Warsch et al. (2013) studied this question.

synapsesocial.com/papers/6a195ea0a0353395e9583edchttps://doi.org/10.1182/blood-2013-02-485573
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Small molecular compounds in development for rheumatoid arthritis2013 · 37 citations
  2. 2Imatinib mesylate discontinuation in patients with chronic myelogenous leukemia in complete molecular remission for more than 2 years2006 · 538 citations
  3. 3Breakthroughs in myeloproliferative neoplasms2012 · 7 citations